The Spring Meeting of the Head and Neck Group took place in PORTO, Portugal.
The Chair Professor Vincent Greogoire welcome the participants.
Important protocols were presented and discussed, such as: the volume reduction through chemotherapy or surgery, immunotherapy in locally advanced disease or in the postop setting, biomarkers in personalized treatments, and other protocols.
Professor Roberto Maroldi presented the promising use of Radiomics in head and neck oncology.29